• Order within –h –m
  • Free shipping on orders over $250
  • Free Bacteriostatic Water 30ml with $500+ purchase
  • Every batch tested by an independent lab

BPC-157 10mg

$89.00

CAS: 137525-51-0 · MW: 1419.5 Da · Purity: ≥99% by reverse-phase HPLC · Format: 10 mg powder · Identity: ESI-MS confirmed

31 in stock

In Stock

COA verified · View report

Purchase & earn 89 points.
Quantity pricingSave up to 20%
QuantityPrice / vialSavingsAdd
1 vial$89.00–
3 vials$84.55Save 5%
5 vials$80.10Save 10%
10 vials Best value$71.20Save 20%

Purity Guarantee: Every vial is backed by independent third-party domestic lab and Janoshik analytical verification.

  • Third-Party TestedIdentity + purity, every batch. Secondary testing on rotation.
  • Janoshik Analytical3rd party domestic labs verified
  • Same-Day ShippingOrder by 2 PM PST, ships today
  • Ships from California2 Day UPS Air. Free shipping over $250

Research use only. Not for human consumption. Sold to qualified researchers.

Accepted:
  • Visa
  • Mastercard
  • Amex
  • Discover
  • Apple Pay
  • Zelle
  • ACH
  • Bitcoin, 10% off

BPC-157 is a short peptide that comes from a protective protein found in the stomach, which is where the “Body Protection Compound” name comes from. Researchers study it heavily in angiogenesis and gut models, and it is one of the peptides that recently drew FDA attention in the 2026 compounding review. This is the 10 mg vial, supplied as a reference material for that research.

Description

Structure & Identity

BPC-157 is a pentadecapeptide, a chain of fifteen amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is a partial sequence derived from a larger gastric protein, and it is notably stable, holding up in conditions that would break down many peptides. That stability is a practical advantage in the lab.

Research Background

BPC-157 research spans gastric-cell signaling, cytoprotection signaling, and blood-vessel (angiogenesis) signaling.

  • Gastric origin. BPC-157 is a partial sequence of a protective protein found in gastric juice, and it is notably stable [PMID: 30915550].
  • Gastrointestinal models. It was studied early in gastric-cell and GI-signaling contexts, including the related PL-14736 [PMID: 17186181].
  • Cytoprotection signaling. Reviews describe its role in cytoprotection and growth-factor signaling across research models [PMID: 30915550].
  • Angiogenesis. Recent work examined its relation to blood-vessel formation and nitric-oxide signaling [PMID: 41155565].
  • Gastric-cell models. It has been studied in drug-challenged gastric-cell models in rats [PMID: 33376304].

These are research contexts, not approved uses, and the peptide is intended purely for laboratory study.

Specifications

Attribute Value
Chemical name BPC-157 (body protection compound-157)
Also Known As Body Protection Compound 157, PL-14736 (related)
Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
CAS number 137525-51-0
Molecular formula C62H98N16O22
Molecular weight 1419.5 g/mol
Purity ≥99% by reverse-phase HPLC
Length 15 amino acids
Identity Confirmed by ESI mass spectrometry
Physical form Lyophilized powder
Appearance White to off-white solid
Quantity 10 mg per vial
Storage -20°C, protected from light
Solubility Soluble in bacteriostatic or sterile water
Classification Research use only

Storage & Handling

Keep the sealed vial frozen at -20°C and shielded from light until use. After preparing, store the solution at 2-8°C and use it in your research within about two weeks. BPC-157 is relatively stable for a peptide, but warming the vial to room temperature before opening and avoiding repeated freeze-thaw cycles are still worthwhile habits that protect the material.

Storage and Handling Guide

Quality Assurance

BPC-157 is produced under research-grade manufacturing controls and released only after an outside lab has verified it. Purity is measured by reverse-phase HPLC and identity by mass spectrometry, with that testing carried out by independent third-party laboratories, including Janoshik Analytical and domestic US labs. A certificate of analysis is issued for each batch, so its figures match the exact vial you receive.

Quality & Testing

Frequently Asked Questions

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide derived from a protein in gastric juice. It is studied in angiogenesis and gastrointestinal research and is supplied for research use only.

What does “BPC” stand for?

Body Protection Compound. The name reflects the gastric protein the peptide’s sequence comes from, which is the origin of most of its research interest.

Why is BPC-157 considered stable?

It resists breakdown better than many peptides, holding up in conditions that would degrade others. That stability makes it convenient to handle and study in the lab.

Is BPC-157 FDA approved?

No. BPC-157 is not FDA approved. In 2026 an FDA advisory committee recommended it for a compounding list, but that is not an approval. The material here is a research-use-only reference peptide, not for human or veterinary use.

What is BPC-157’s sequence and molecular weight?

Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, its formula is C62H98N16O22, and its molecular weight is about 1419.5 g/mol, with CAS number 137525-51-0.

How is BPC-157 different from TB-500?

They are studied across overlapping pathways but are different molecules, BPC-157 around angiogenesis and TB-500 around actin and cell migration.

How should BPC-157 be stored?

Keep the powder frozen at -20°C and protected from light. Once reconstituted for research, store the solution at 2-8°C and use within about two weeks.

How is this BPC-157 verified?

It is tested to ≥99% purity by reverse-phase HPLC with mass-spec identity confirmation by an independent lab, and each batch ships with its own certificate of analysis.

References

  1. Stable gastric pentadecapeptide BPC 157 in trials for gastrointestinal models (PL-14736). 2006. PMID: 17186181.
  2. Gastric pentadecapeptide BPC 157: cytoprotection and growth-factor signaling. 2019. PMID: 30915550.
  3. BPC 157: targeting angiogenesis and nitric oxide signaling. 2025. PMID: 41155565.

Additional information

Weight 0.03 kg

Published research

Selected literature

Peer-reviewed studies that describe the research context for this compound. Listed for reference, not as a claim about use.

  • Gastrointestinal ModelBPC 157 (PL-14736) in GI-cell signaling research.PubMed 17186181
  • BPC-157 Signaling ReviewAngiogenesis and cytoprotection models.PubMed 30915550
  • Angiogenesis & Nitric OxideBPC 157 and blood-vessel signaling.PubMed 41155565
  • Foundational Gastric StudyEarly BPC 157 gastric-cell research.PubMed 10672992
  • Gastric-Cell Model (rat)BPC 157 and gastric-cell readouts. PubMed 33376304

Related products